Gene expression profiling of leukemic cells and primary thymocytes predicts a signature for apoptotic sensitivity to glucocorticoids
2007

Gene Expression Profiling in Leukemia Cells and Thymocytes

Sample size: 6 publication 10 minutes Evidence: moderate

Author Information

Author(s): Aaron L. Miller, Spogmai Komak, M. Scott Webb, Edward H. Leiter, E. Brad Thompson

Primary Institution: The University of Texas Medical Branch

Hypothesis

A common set of glucocorticoid-regulated genes can be identified in various hematologic malignancies sensitive to glucocorticoid-induced apoptosis.

Conclusion

The study identified a set of genes that correlate with glucocorticoid sensitivity in cells from several hematologic malignancies.

Supporting Evidence

  • Glucocorticoids are known to induce apoptosis in sensitive leukemia cells.
  • Gene expression profiles were compared across multiple leukemia cell lines.
  • Certain genes were found to be consistently regulated in both sensitive and resistant cell lines.

Takeaway

Researchers looked at how certain genes behave in leukemia cells when treated with glucocorticoids, which are medicines that can kill cancer cells. They found some genes that help predict how sensitive these cancer cells are to the treatment.

Methodology

Microarray technology was used to compare gene expression signatures in various hematologic cells treated with glucocorticoids.

Limitations

The gene set identified may be incomplete due to the limitations of the microarray technology used.

Participant Demographics

The study involved pediatric and adult leukemia cell lines.

Statistical Information

P-Value

p ≤ 0.05

Statistical Significance

p ≤ 0.05

Digital Object Identifier (DOI)

10.1186/1475-2867-7-18

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication